Latest / Stock Movers / Oracle Surges; Kyndryl, Hims & Hers Health Plummet
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: I'm Tim Steneveek along with Carol Master. Let's take a
- 0:18Speaker 1: look at some stocks on the move today with us
- 0:20Speaker 1: as Bloomberg News Equities reporter and Deputy team leader for
- 0:22Speaker 1: US Equities Carmen Ryanikey Carmen lot to choose from on
- 0:26Speaker 1: the upside and the downside as we get close to
- 0:29Speaker 1: the end of the trading day. What's on your radar?
- 0:31Speaker 3: Yeah, so the first one I'm looking at is Oracolene.
- 0:33Speaker 3: You're saying tech share is looking really good today. This
- 0:35Speaker 3: is one that we're definitely seeing getting a little bit
- 0:37Speaker 3: of a boost, maybe a rebound from the software saf
- 0:40Speaker 3: that we saw last week. So ticker orcl shares her
- 0:43Speaker 3: up about eleven percent right now. This is the most
- 0:46Speaker 3: sense September tenth for this stock. It's been pretty beaten
- 0:49Speaker 3: up lately. It looks like there's just enthusiasm around all
- 0:54Speaker 3: of this capex that we're seeing sort of pledged from
- 0:56Speaker 3: the biggest companies, you know, Amazon, Microsoft, Google, and there's
- 1:00Speaker 3: also an upgrade on this today, So DA Davidson analyst
- 1:04Speaker 3: Gileria upgraded the stock to buy from neutral. He also
- 1:08Speaker 3: noted that the firm is feeling more optimistic about the
- 1:11Speaker 3: company's relationship with open Ai. So that's something that's kind
- 1:14Speaker 3: of come into question previously for the stock, just if
- 1:18Speaker 3: those deals were going to, you know, be beneficial overall.
- 1:22Speaker 4: You know what's really wild too, is, yeah, Bernstein cut
- 1:26Speaker 4: their price target on the stock. It's like, I feel
- 1:30Speaker 4: like there were a bunch of a fair amount of
- 1:32Speaker 4: maybe a few other analysts, but you're right, it's like
- 1:34Speaker 4: the streets focusing on what we got from DA Davidson
- 1:37Speaker 4: and what they had to say. So I just find
- 1:39Speaker 4: that I don't know.
- 1:41Speaker 1: Well, shameless plug for one of our chats last week
- 1:44Speaker 1: with Guillaria, he joined us. Yeah yeah, check it out
- 1:48Speaker 1: on the podcast feed.
- 1:49Speaker 4: Yeah, he's super interesting, right yeah, yeah, all right, all right,
- 1:53Speaker 4: So we're keeping a watch an Oracle definitely on the
- 1:55Speaker 4: move KD ticker, which.
- 1:57Speaker 3: Is kindrel So this was spun off from ib it's
- 2:00Speaker 3: an it it's another tech company. So there's a lot
- 2:03Speaker 3: going on here. The stock is down about fifty six
- 2:06Speaker 3: percent right now. This is a record drop so a
- 2:09Speaker 3: few things happened this morning. The company reported earnings that
- 2:11Speaker 3: were a little bit less than Wall Street expected, but
- 2:13Speaker 3: in addition said there was some leadership changes, so CFO left,
- 2:19Speaker 3: general counsel left, and then there was a switch in
- 2:22Speaker 3: one other leadership position.
- 2:24Speaker 2: And still this year.
- 2:26Speaker 3: They also said the company received a voluntary documents review
- 2:30Speaker 3: from the US Securities Exchange Commission's Division of Enforcements, so
- 2:34Speaker 3: they're reviewing a lot of their financial practices. They're saying
- 2:38Speaker 3: that they don't anticipate any financial impact from this, but
- 2:43Speaker 3: they have delayed some of quarterly filings and say that
- 2:48Speaker 3: they are expecting to report material weakness in the quarter
- 2:52Speaker 3: full fiscal year and the first two quarters of their
- 2:55Speaker 3: fiscal twenty twenty six.
- 2:56Speaker 1: And they also missed earing next today exactly.
- 2:58Speaker 3: Right, Well that was the first thing, you know, that
- 3:00Speaker 3: they missed earnings, but there was a lot of other
- 3:03Speaker 3: things going on AFRO exactly.
- 3:05Speaker 1: That's what people are focused on.
- 3:07Speaker 4: Well, I'm like, it's down so much here to date,
- 3:08Speaker 4: that's because of the slide today.
- 3:11Speaker 1: Yeah, but this was so this was spun off from
- 3:13Speaker 1: IBM back in twenty twenty one and sort of like
- 3:15Speaker 1: the legacy services business but yeah, I decline of more
- 3:20Speaker 1: than fifty percent, and at one point a trading volatility
- 3:23Speaker 1: pause too.
- 3:23Speaker 3: Yeah, it was paused on the downside and then actually
- 3:26Speaker 3: back up on the upside. And now yeah, trading off
- 3:29Speaker 3: of the very very lows of the day. But record,
- 3:31Speaker 3: I mean it also, you know, got a downgrade today
- 3:33Speaker 3: from JP Morgan. So just a lot of negative catalysts.
- 3:36Speaker 4: I know you have those mondays where you're like, I
- 3:38Speaker 4: just didn't have come to work. I should point out
- 3:40Speaker 4: it was down twenty three percent last year. In twenty
- 3:43Speaker 4: twenty four, it was up sixty six percent. In twenty
- 3:45Speaker 4: twenty three, it was up almost eighty seven percent. So
- 3:49Speaker 4: it has had a run, but certainly not the case
- 3:51Speaker 4: so far this year. And now to a name that
- 3:54Speaker 4: I feel like we're all thinking about post super Bowl
- 3:57Speaker 4: because they had one of the commercial spots. Maybe we're
- 3:59Speaker 4: not all thinking you.
- 4:01Speaker 1: Ended up aywashing the whole thing.
- 4:02Speaker 4: That's why I'm a little crazy today. Hyms and Hers Health.
- 4:06Speaker 3: Yeah, hyms and Hers so ticker each I asked shares
- 4:08Speaker 3: are down about nineteen percent right now, most since June.
- 4:12Speaker 3: So Nova Nordisk said that it's suing the company for
- 4:15Speaker 3: making knockoffs of its OBCD medicines. So Hyms had previously
- 4:20Speaker 3: said that it was going to sell sort of a
- 4:21Speaker 3: copycat version of the weight loss pill. It said earlier
- 4:24Speaker 3: this week ab we were Saturday over the weekend that
- 4:26Speaker 3: it's scrapped those plans. It's not going to sell this
- 4:29Speaker 3: copycat version. But Novo's still is saying it's going to
- 4:33Speaker 3: sue Hymns in hers. So shares are down on that.
- 4:36Speaker 3: And actually, let's look, Novo ADRs were up a little
- 4:38Speaker 3: bit today when I looked earlier, about five percent.
- 4:43Speaker 2: The stock Mover's report from Bloomberg Radio. Check back with
- 4:47Speaker 2: us throughout the day for the latest roundup of companies
- 4:50Speaker 2: making news on Wall Street and for the latest market
- 4:53Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:57Speaker 2: Bloomberg dot com, and on applecar Play and Android Auto with
- 5:01Speaker 2: the Bloomberg Business app MHM